Harte-Hanks, Inc. (HHS) Misses Q3 EPS by 1c
Harte-Hanks, Inc. (NYSE: HHS) reported Q3 EPS of $0.19, $0.01 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $212.79 million versus the consensus estimate of $213.03 million.